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Abstract Pleckstrin homology (PH) domains are 100^120
amino acid protein modules best known for their ability to bind
phosphoinositides. All possess an identical core L-sandwich fold
and display marked electrostatic sidedness. The binding site for
phosphoinositides lies in the center of the positively charged face.
In some cases this binding site is well defined, allowing highly
specific and strong ligand binding. In several of these cases the
PH domains specifically recognize 3-phosphorylated phospho-
inositides, allowing them to drive membrane recruitment in
response to phosphatidylinositol 3-kinase activation. Examples
of these PH domain-containing proteins include certain Dbl
family guanine nucleotide exchange factors, protein kinase B,
PhdA, and pleckstrin-2. PH domain-mediated membrane re-
cruitment of these proteins contributes to regulated actin
assembly and cell polarization. Many other PH domain-
containing cytoskeletal proteins, such as spectrin, have PH
domains that bind weakly, and to all phosphoinositides. In these
cases, the individual phosphoinositide interactions may not be
sufficient for membrane association, but appear to require self-
assembly of their host protein and/or cooperation with other
anchoring motifs within the same molecule to drive membrane
attachment. ß 2002 Federation of European Biochemical So-
cieties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Three reports in 1993 [1^3] pointed out the existence of a
100^120 residue stretch of amino acid sequence similarity in
many proteins involved in cellular signaling, cytoskeletal orga-
nization, and other processes. This region of homology was
proposed to de¢ne a protein module or domain, and was
named the pleckstrin homology (or PH) domain since it had
¢rst been described by Haslam and colleagues as an internally
repeated motif in the hematopoietic protein pleckstrin [4]. PH
domains are now known to occur in a very large number of
proteins, from yeast to mammals. The ¢rst draft of the human
genome sequence [5] indicates that 252 di¡erent human pro-
teins contain at least one PH domain, making it the 11th most
common domain in humans. In Saccharomyces cerevisiae,
some 27 di¡erent proteins contain a total of 36 PH domains,
making the PH domain the 17th most common yeast domain
[6]. The sequence characteristics used to identify PH domains
appear to de¢ne a particular protein fold that has now been
seen in the X-ray crystal structures and/or nuclear magnetic
resonance (NMR) structures of some 13 di¡erent PH domains
[7^12]. Each of these PH domains possesses an almost iden-
tical core L-sandwich structure (described below), despite pair-
wise sequence identities between PH domains that range from
only around 10% to 30% in the best cases.
Although it is often assumed that all PH domains share a
common function, they may instead share only the PH do-
main fold, and form subclasses with quite di¡erent functions.
Recent studies have demonstrated that some PH domains can
drive protein association with membranes through direct and
speci¢c recognition of polyphosphoinositides [7]. However,
this is now realized to be a property of only a small fraction
of PH domains [7,13] ^ perhaps just 10%. This raises the
question as to how the other 90% function. Most of the these
PH domains do appear to bind phosphoinositides, but do so
very weakly and with little discernible speci¢city. This argues
either that most PH domains require assistance from other
domains in order to achieve their function, or that the phys-
iological ligands of PH domains are not limited to polyphos-
phoinositides. We will discuss example of these possibilities in
proteins involved in signaling and cytoskeletal function.
2. PH domain structure
As mentioned above, 13 di¡erent PH domain structures are
known, and all share the same L-sandwich fold ¢rst observed
in NMR structures of the N-terminal pleckstrin PH domain
[14] and the L-spectrin PH domain [15]. The fold is illustrated
in Fig. 1 for the L-spectrin PH domain. The amino-terminal
half of the protein forms a four-stranded L-sheet, with an
additional short K-helix in the L3/L4 loop (speci¢c to the
L-spectrin PH domain). The second half of the protein forms
a L-sheet meander (strands L5^L7) that is near-orthogonal to
the ¢rst sheet. The two sheets form a ‘sandwich’ that is ¢lled
with the hydrophobic core of the domain. To the left and
right of the domain as seen in Fig. 1A are the ‘closed’ corners
of the L-sandwich [16], at which the two sheets approach
closely and are linked by tight turns or the continuation of
L-strands. At the top and bottom of the structure in Fig. 1A
are the two ‘splayed’ corners of the sandwich, which are
capped o¡ (at the top) by the C-terminal K-helix characteristic
of all PH domains and (at the bottom) by the L1/L2, L6/L7
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loops and part of the L3/L4 loops of the domain. The same
L-sandwich fold, with identical size and topology plus a C-ter-
minal K-helix, has also been seen in several other domains
that share no signi¢cant sequence similarity with PH domains
[17]. Included in these examples are the phosphotyrosine bind-
ing (PTB) domain [18], the Ran binding domain (from Ran
binding protein-2) [19], and the Enabled/VASP homology do-
main-1 (EVH1) [20]. Each of these domains recognizes a pro-
tein or peptide ligand in a distinct manner, providing sugges-
tions of how PH domains might recognize putative protein
targets. Like PH domains, PTB domains have also been re-
ported to bind (albeit weakly) to phosphoinositides [18].
3. The PH domain as a polyphosphoinositide binding module
The determination of PH domain structures preceded
understanding of their function. One of the ¢rst physical char-
acteristics to be noted was that PH domains are strongly
electrostatically polarized [15]. When the calculated electro-
static potential around the L-spectrin PH domain is plotted
with a contour level of þ 1.5 kT, a clearly de¢ned region of
positive potential is seen, centered on the L1/L2 loop [15] (Fig.
1B). The remainder of the protein is surrounded by negative
electrostatic potential. Such electrostatic sidedness is a char-
acteristic seen for all PH domains of known structure [17] and
is highly reminiscent of the polarization seen in secretory
phospholipase A2 isozymes [21], which interact with acid
phospholipids in cell membrane surfaces via their positively
charged faces. Fesik and coworkers also noted a similarity
between the PH domain fold and that of retinol binding pro-
tein [14], and this prompted them to propose that PH domains
bind to membrane lipids, speci¢cally to phosphatidylinositol
(4,5)bisphosphate (PtdIns(4,5)P2) [22]. They demonstrated
that several PH domains can bind this relatively abundant
component of the cytoplasmic face of cell membranes [22],
and many subsequent studies have indicated that polyphos-
phoinositide binding is a property shared by most, if not all,
PH domains [7,13,23].
However, in only very few cases is phosphoinositide binding
by PH domains of high a⁄nity and speci¢city. By far the
majority of described PH domain/phosphoinositide interac-
tions (90% or so) are of low a⁄nity (KD = 10 WM) and display
little to no stereospeci¢city. Most known PH domain interac-
tions with high a⁄nity and speci¢city have now been studied
extensively, and all appear to represent cases where phospho-
inositide binding by the PH domain is both su⁄cient and
necessary to drive membrane targeting of the PH domain-
containing protein. One example of this is seen with phospho-
lipase C-N1 (PLC-N1), the N-terminal PH domain of which is
required for plasma membrane association of PLC-N1 in vivo
[24]. The PLC-N1 PH domain speci¢cally recognizes
PtdIns(4,5)P2 with high a⁄nity (KDW1.7 WM) [7,13], and lo-
calizes strongly to the plasma membrane when expressed
alone in yeast or mammalian cells [24^26]. Along similar lines,
the PH domain at the amino-terminus of protein kinase B
(PKB), also known as Akt, speci¢cally recognizes both
PtdIns(3,4)P2 and PtdIns(3,4,5)P3 [27,28], lipid second mes-
sengers that occur at signi¢cant levels in the plasma mem-
Fig. 1. A: Ribbon representation of the PH domain from L-spectrin, using coordinates from the X-ray crystal of Hyvo«nen et al. [33] (from
which the bound Ins(1,4,5)P3 has been removed). Conserved elements of secondary structure are labeled. This ¢gure was generated using MOL-
SCRIPT [59]. B: The L-spectrin PH domain is shown in the same orientation as in A, with the calculated electrostatic potential shown, con-
toured at 31.5 kT (red) and +1.5 kT (blue). The backbone of the PH domain is represented by a gray worm. This ¢gure was generated with
GRASP [60].
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brane only after phosphatidylinositol 3-kinase (PI 3-kinase)
activation by cell surface receptor agonists [29]. PKB is re-
cruited to the plasma membrane by binding of its PH domain
to these transiently occurring lipid second messengers [30],
providing a mechanism for direct regulation of PKB by ago-
nist-stimulated PI 3-kinases [31,32].
4. Low-a⁄nity binding of polyphosphoinositides to PH domains
While ‘high-a⁄nity’ PH domains can function independ-
ently as signal-regulated membrane-targeting modules, the
function of PH domains that bind only weakly and non-spec-
i¢cally to polyphosphoinositides is less clear. However, there
is a great deal of evidence supporting the importance of these
PH domains and a role for their weak phosphoinositide in-
teractions. The L-spectrin PH domain and the N-terminal
pleckstrin PH domain both bind PtdIns(4,5)P2 with low a⁄n-
ity (KD in the 30^50 WM range) and poor speci¢city [22,33].
NMR studies showed that the positively charged face of
the N-terminal pleckstrin PH domain is responsible for
PtdIns(4,5)P2 binding to this domain [22]. Similarly, a crystal
structure of the complex formed between the L-spectrin PH
and inositol 1,4,5-trisphosphate (Ins(1,4,5)P3), published by
Saraste and coworkers [33], showed that the binding site for
the PtdIns(4,5)P2 headgroup lies in the center of the positively
charged lobe seen in Fig. 1B. The binding site for Ins(1,4,5)P3
in this case is less well de¢ned or buried than binding sites
seen in structures of high-a⁄nity PH domain complexes [34].
We suggest that the weak interactions seen with the pleck-
strin and spectrin PH domains are driven by rather non-spe-
ci¢c, or delocalized, electrostatic attraction between an
anionic ligand and the positively charged face of the electro-
statically polarized protein domain. In these and several other
cases, inositol phosphates bind with a⁄nities that re£ect the
number of phosphate groups that they contain, rather than
the speci¢c spatial arrangement of these groups [35]. A model
for binding of the L-spectrin PH domain to PtdIns(4,5)P2-
containing membranes, based on studies by Saraste and col-
leagues [33], is presented in Fig. 2. Comparison with the elec-
trostatic representation in Fig. 1B illustrates how docking of
the PH domain on the membrane, guided by the crystallo-
graphically determined position of the bound headgroup,
Fig. 2. Hypothetical view of how the PH domain from L-spectrin [33] binds to a membrane containing PtdIns(4,5)P2. The X-ray crystal struc-
ture of the L-spectrin PH domain, with bound Ins(1,4,5)P3 [33], is shown in a ribbon representation. The glycerol backbone and fatty acyl moi-
ety from an idealized phospholipid have been added arti¢cially to the Ins(1,4,5)P3 headgroup to generate a hypothetical PtdIns(4,5)P2 structure.
The PtdIns(4,5)P2 is embedded in a model for a dimyristoylphosphatidylcholine bilayer kindly provided by Dr. Herbert Treutlein. L-strands 1^
7 are labeled, as is the C-terminus of the PH domain. This ¢gure was generated using MOLSCRIPT [59].
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abuts the positively charged surface of the domain against the
negatively charged surface of the membrane.
Alone, weak interactions of the sort described here are un-
likely to be su⁄cient to drive membrane association of PH
domain-containing proteins. It remains possible that the phos-
phoinositide binding observed in vitro for these weakly bind-
ing domains has no relevance in vivo, and that protein or
other ligands are more relevant. However, PH domains
from this class tend to remain cytoplasmic when expressed
in isolation, arguing against clear membrane targets that
have simply not yet been identi¢ed. It therefore seems most
likely that phosphoinositide binding by the PH domain coop-
erates with other interactions mediated by the same domain,
or by other domains in the same protein (or complex of
proteins) to drive multivalent membrane association. One
piece of evidence for this was reported for the PH domain
from the L-adrenergic receptor kinase (L-ARK), which binds
PtdIns(4,5)P2 with a KD in the 100 WM range [36], but also
appears to bind GLQ subunits of heterotrimeric G proteins
through a C-terminal extension [37]. Neither one of these
interactions alone is su⁄cient for L-ARK membrane associa-
tion. However, simultaneous interaction of the PH domain
with both ligands appears to be su⁄cient to drive e⁄cient
membrane targeting of L-ARK [38]. Similar situations may
occur for PH domains that bind (in addition to phosphoino-
sitides) actin [39], the receptor for activated C-kinase
(RACK1) [40], or protein kinase C [41], which have all been
described.
Weak phosphoinositide binding by a PH domain might
instead cooperate with interactions mediated by an entirely
separate domain within the same protein, as has been ob-
served for the Rac1 guanine nucleotide exchange factor
Tiam-1. The N-terminal PH domain and a separate protein
binding domain must cooperate to drive appropriate subcel-
lular targeting of Tiam-1 [42]. Other examples are provided by
pleckstrin with its two PH domains (see below), and several
other molecules in which more than one lipid binding modules
cooperate to drive membrane association. The di¡erent do-
mains that cooperate in driving membrane association may
be in the same protein or in di¡erent proteins. If they are in
separate proteins (in a homo- or heteromeric complex), then
regulation of oligomer formation could control membrane
targeting, as has been suggested for the large GTPase dyna-
min [43].
5. PH domains and the cytoskeleton
Many cytoskeletal proteins and proteins that regulate the
cytoskeleton contain PH domains. Some have PH domains
from the speci¢c and high-a⁄nity class discussed above.
Some have PH domains that bind phosphoinositides with
low a⁄nity and speci¢city. Still others appear to show signi¢-
cant speci¢city for 3-phosphorylated phosphoinositides (if not
always high a⁄nity). Regulation of membrane association in
each case is likely to be fundamentally di¡erent. For proteins
with high-a⁄nity and speci¢c PH domains, simple alteration
of lipid species in the membrane can directly alter membrane
association. Regulated membrane association of proteins with
low-a⁄nity, non-speci¢c PH domains need not involve alter-
ation of lipids in the membrane, but may instead require
modulation of protein^protein interactions. Proteins with
low-a⁄nity PH domains that show some phosphoinositide
speci¢city may respond to simultaneous changes in phospho-
inositide pro¢le and protein^protein interactions.
5.1. Dbl family GEFs
Dbl family proteins are guanine nucleotide exchange factors
(GEFs) that mediate activation of Rac/Rho family small
GTPases by catalyzing the exchange of bound GDP for
GTP. GEF activation of Rac/Rho GTPases plays a critical
role in actin assembly initiated by all cell surface receptors.
Every Dbl family protein contains a Dbl homology (DH)
domain responsible for its GEF activity [44], which is always
immediately followed by a PH domain. Ligand binding to the
PH domain is thought to regulate DH domain activity. In the
case of Vav-1, it has been proposed that PI 3-kinase products
bind to the PH domain and enhance the ability of the DH
domain to activate Rac/Rho GTPases. Supporting this hy-
pothesis, high concentrations of PtdIns(3,4,5)P3 were reported
to enhance Vav-1 exchange activity in vitro [45]. Interestingly,
the same study indicated that PtdIns(4,5)P2 inhibits the ex-
change activity of Vav-1 [45], suggesting that the PH domain
may exert a negative in£uence on Vav activity, and that
PtdIns(3,4,5)P3 (but not PtdIns(4,5)P2) can somehow relieve
this inhibition. In line with this hypothesis, deletion of the PH
domain from Vav-1 was recently shown to result in a mutant
with constitutive in vivo exchange activity [46]. Similarly, the
PH domain of Sos was reported to have an inhibitory e¡ect
upon its DH domain in vivo, and this could be relieved by
deletion of the PH domain [47]. Based on these observations
and on structural studies it has been suggested that the PH
domain of a DH/PH pair may block access to the binding site
for the Rac/Rho small G protein on the DH domain [11,48].
Phosphoinositide binding to the PH domain could alter the
average position of the PH domain with respect to the DH
domain and thus relieve this steric block, although precise
details of how this might occur are far from clear. Most PH
domains that follow DH domains appear to exhibit both low
a⁄nity and poor speci¢city for phosphoinositides [49], sug-
gesting that the regulatory mechanism is more complicated
than suggested in this simple view. Furthermore, binding of
phosphoinositides to the PH domain does not alter in vitro
DH domain activity under all conditions [49]. Clearly, a great
deal more work is required in order to fully understand the
role of the PH domain in controlling the adjacent DH domain
in Dbl family members.
5.2. PH domains in cell polarization and chemotaxis
Several recent studies have indicated that PH domains play
critical roles in the spatial regulation of actin assembly re-
quired for proper chemotaxis ^ providing a clear link between
PH domains and coordination of cytoskeletal organization.
This link appears to involve PI 3-kinase activation. Protein
kinase B or its isolated PI 3-kinase product binding PH do-
main has been shown to localize speci¢cally to the leading
edge of chemotaxing cells [50]. So have the Dictyostelium pro-
teins CRAC and PhdA, which both have PH domains likely
to bind PI 3-kinase products. In mammalian neutrophils [51]
and in Dictyostelium [52,53], it has been demonstrated dra-
matically with GFP fusion proteins that the PH domains of
PKB, CRAC, and PhdA acquire a highly polarized localiza-
tion upon application of a chemotactic stimulus gradient.
A requirement for PKB in directing cell polarity is sug-
gested by the ¢nding that PKB-de¢cient Dictyostelium do
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not extend pseudopodia in a polarized manner following ex-
posure to chemoattractant gradients [54]. PhdA is one of the
PH domain-containing proteins that localize to the leading
edge of Dictyostelium when exposed to a cAMP gradient
[53]. Polarized PhdA localization is clearly PI 3-kinase-depen-
dent, and it has been shown both that loss-of-function muta-
tions in PhdA lead to defects in actin polymerization at the
leading edge of chemotaxing cells, and that dominant negative
PhdA mutations impair pseudopod formation at the leading
edge [53]. A model has thus emerged in which localized pro-
duction of PI 3-kinase products is thought to recruit PhdA via
its PH domain, with PhdA then serving as a sca¡olding pro-
tein to localize other proteins required for actin assembly at
the leading edge.
5.3. Pleckstrin
Pleckstrin is well known because it contains the two proto-
typic PH domains, which individually appear to bind phos-
phoinositides with relatively low a⁄nity and poor speci¢city.
Pleckstrin is expressed only in hematopoietic cells, where it is
one of the most abundant proteins, accounting for approxi-
mately 1% of total cellular protein. Pleckstrin was initially
described as a prominent substrate of PKC [4], and pleckstrin
activity is regulated by PKC phosphorylation at three sites
immediately adjacent to the N-terminal PH domain [23].
Once phosphorylated, pleckstrin is a negative regulator of
3- and 5-polyphosphoinositide production. When expressed
in a variety of transformed and primary cell lines, PKC-phos-
phorylated pleckstrin causes a dissolution of stress ¢bers, en-
hanced cell spreading, and appearance of morphology sug-
gesting increased F-actin levels [23]. Some of these e¡ects
may arise directly from the ability of pleckstrin to associate
with phospholipids via its two PH domains, since phospho-
lipids contribute to actin organization by regulating actin cap-
ping and GEFs. However, the e¡ects were also shown to in-
volve activation of Rho family GTPases and integrins [55,56].
In addition to the hematopoietic-restricted pleckstrin, a
widely expressed paralog, named pleckstrin-2, exists [57].
Pleckstrin-2 has a similar domain structure to pleckstrin, but
is not regulated by PKC. The PH domains of pleckstrin-2
appear to show a much higher speci¢city for PI 3-kinase
products than do their pleckstrin counterparts. Consistent
with this, it has been found that pleckstrin-2 induces ru¥e
formation and cell spreading in a PI 3-kinase-dependent man-
ner [57]. As proposed for the regulators of cell polarity in
chemotaxis, it is likely that pleckstrin-2 contributes to local
actin organization once recruited to membranes by binding to
PI 3-kinase products.
5.4. Cytoskeletal proteins with PH domains that do not bind
PI 3-kinase products
Speci¢c, regulated recruitment of PH domain-containing
proteins to regions at which PI 3-kinase products are gener-
ated appears to participate in spatial organization of the cy-
toskeleton in several of the examples given above. For illus-
tration, this process appears to result in nucleation of actin
polymerization at the leading edge of chemotaxing cells. How-
ever, not all PH domains in cytoskeletal proteins bind PI 3-
kinase products, suggesting that this mechanism does not al-
ways apply. As mentioned previously, the L-spectrin PH do-
main, for example, binds weakly to all phosphoinositides. It is
likely that the physiological ligand of such PH domains is the
most abundant polyphosphoinositide, PtdIns(4,5)P2. The
likely structural basis for PtdIns(4,5)P2 binding by the L-spec-
trin PH domain is represented in Fig. 2. Note that the pos-
itively charged face of the domain seen in Fig. 1A directly
faces the negatively charged membrane surface. Spectrin as-
semblies or networks contain many spectrin molecules, and
therefore many PH domains. Such assemblies will be capable
of high-avidity (multivalent) PH domain-mediated membrane
association that will be very strong in spite of the fact that
each single PH domain interaction with PtdIns(4,5)P2 is weak.
It is likely that much of the membrane attachment of the
cytoskeleton is achieved through this type of multivalent in-
teraction with membrane lipids. Such a mechanism allows for
a situation in which only assembled cytoskeletal components,
and not the individual proteins, will bind strongly to cellular
membranes. Raucher et al. [58] have elegantly shown using
laser tweezers that PtdIns(4,5)P2 plays an important role in
adhesion of the cytoskeleton to the plasma membrane. They
speci¢cally sequestered cellular PtdIns(4,5)P2 by over-expres-
sion of the PH domain from PLC-N1, and found that the
adhesion energy between the cytoskeleton and the plasma
membrane was reduced signi¢cantly. Several cellular stimuli
known to depress PtdIns(4,5)P2 levels had similar e¡ects.
6. Conclusion
Many cytoskeletal proteins contain domains that bind
phosphoinositides, the PH domain being just one example
of several classes. How membrane attachment of these pro-
teins is regulated and remodeled in vivo is only just beginning
to be elucidated. An appreciation is growing that cytoskeletal
and associated proteins, when membrane-bound, will also di-
rectly a¡ect the distribution and accessibility of phosphoino-
sitides in the membrane. The consequences of this, and how it
participates in cellular control, will be the focus of intensive
investigation as tools are sharpened for analyzing phospholip-
ids in living cells.
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